Cardiovascular | Minimal Risk

Pravastatin (Pravachol)

Pravastatin risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Pravachol, Lipostat 40, Cholstat 40, Pravastatin Sandoz, APX-Pravastatin and 6 more.

Source: PBS, TGA Updated April 2026

Pravastatin (brand names: Pravachol, Lipostat 40, Cholstat 40, Pravastatin Sandoz, APX-Pravastatin and 6 more) is classified as Minimal risk by AllMeds. It is a S4 medication under the TGA in Australia. Cholesterol-lowering medication with excellent safety profile and no workplace impairment risk.

Key Takeaways

  • TGA Schedule: S4 in Australia
  • Risk level: Minimal (0 points)
  • PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S4 PBS listed

Risk Profile

Risk Level Minimal
Risk Points 0
CNS Depressant No
Respiratory Risk No

Cholesterol-lowering medication with excellent safety profile and no workplace impairment risk.

Regulatory and Compliance Guidance

When Pravastatin appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Need to assess this medication across your caseload?

Run a full risk assessment including Pravastatin interactions and compliance checks.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

No credit card required. No signup for your first 2 questions.

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.